n = 79 (male: 44, female: 35) | ||||
mean age | 68.9 ± 12.6 y.o. | |||
injected eye | Phase 1 | Phase 2 | Phase 3 | repeated measure test |
implicit time | 31.2 ± 3.2 | 31.7 ± 3.1a | 32.2 ± 3.3a | p < 0.00001 |
(msec.) | p = 0.00034 | p < 0.00001 | ||
amplitude | 8.7 ± 5.7 | 7.9 ± 6.1 | 9.5 ± 8.9 | p = 0.12 |
(uV) | p = 0.5 | p = 0.92 | ||
non-injected eye | Phase 1 | Phase 2 | Phase 3 | repeated measure test |
implicit time | 30.5 ± 3.3 | 31.1 ± 3.18a | 31.3 ± 3.4a | p = 0.000018 |
(msec.) | p = 0.0084 | p = 0.00002 | ||
amplitude | 9.4 ± 6.5 | 9.2 ± 6.7 | 9.5 ± 6.2 | p = 0.72 |
(uV) | p = 1 | p = 1 |